Search

You searched for "ESU"

200 results found
European Urology journal front cover.

Multiparametric MRI with targeted-only biopsy – a new standard?

21 November 2025 | | URO - Urologic Oncology
In this issue of European Urology, Kasivisvanathan et al. present a meta-analysis of two randomised trials comparing prebiopsy MRI with targeted biopsy (TBx) alone versus standard transrectal ultrasound-guided biopsy (TRUS-Bx) in biopsy-naïve men at risk of prostate cancer. Their findings...

Retroperitoneal sepsis

1 September 2016 | | URO - Infection
Case 1 An 80-year-old woman presented with history of recurrent and recent cystitis, low grade pyrexia, abdominal and back pain, and pain on movement of the left hip which was observed to be flexed and externally rotated. What is the...

RSM: Andrology update 2026: advances across benign and oncological practice

11 December 2026
Join the Royal Society of Medicine (RSM) Urology Section, in collaboration with the British Association of Urological Surgeons (BAUS) Section of Andrology and the British Society of Sexual Medicine, for this one-day meeting exploring the latest developments in andrology, penile cancer and testicular cancer. Returning for its biannual meeting, the programme brings together leading surgeons, physicians, psychologists and specialist nurses, and will examine advances in clinical practice across benign andrology, penile cancer and testicular cancer.
European Urology journal front cover.

Why perform PLND?

7 October 2026 | | URO - Urologic Oncology
Pelvic lymph node dissection (PLND) during radical prostatectomy has historically been recommended for staging purposes and a potential oncological benefit. Extended PLND (ePLND) provides more accurate staging, detecting more lymph node (LN) metastases than limited PLND (lPLND). This information helps...

Visual-estimation (cognitive), image-fusion (software) and in-bore targeted prostate biopsy: is there an optimal approach?

3 March 2021 | | URO - Urologic Oncology, URO - Technology
The diagnostic superiority of multiparametric magnetic resonance imaging (mpMRI) prior to targeted and systematic prostate biopsy over systematic transrectal ultrasound-guided (TRUS) biopsy alone in the detection of clinically significant prostate cancer (csPCa) has been proven by multiple level 1 studies...

Female and functional

13 March 2023 | | URO - Core Urology
Case 1 A 65-year-old woman presents with an 18-month history of “recurrent urinary tract infections” (rUTI). She is otherwise fit and well with no underlying medical problems and no lower urinary tract symptoms. What is the definition of a UTI...

Urolithiasis 3 – renal stones and ureteroscopy

7 May 2026 | | URO - Endourology & Stones, URO - Uroradiology
- Click for Part 1 and Part 2 on this topic - Case scenario A 36-year-old man with a known renal stone attends your stone clinic following a surveillance CT KUB with worsening intermittent right flank pain. Figures 1 and...

Penile cancer

1 July 2021 | | URO - Urologic Oncology
Case 1 A 67-year-old man presents with a worsening red patch over the past three months. It looks velvety in some areas. What is the most likely diagnosis? What are the risk factors? How do you classify this condition? How...

An overview of non-surgical treatment options for Peyronie’s disease

3 May 2022 |
Peyronie’s disease (PD) is a therapeutic challenge despite the availability of several non-surgical and surgical options. Very few of these options are supported by good quality evidence according to the current American and European guidelines [1-3]. The period of plaque...

Peno-scrotal extramammary Paget’s disease

1 July 2015 | | URO - Infection
Epidemiology Extramammary Paget’s disease (EMP) is a rare intraepithelial neoplasm, which is rarely invasive and has an incidence of six per million person-years as calculated by a European SEER analysis [1]. It usually affects apocrine gland-bearing areas, especially the vulvar,...

The role of PET-CT imaging in prostate cancer

4 October 2021 | | URO - Urologic Oncology
Prostate cancer (PCa) is the second most common cancer in the UK, with 43,000 cases in 2017-18 [1,2]. Accurate primary staging and the detection of suspected recurrence following treatment is vital for directing management and predicting prognosis. This has conventionally...

Biomarkers in prostate cancer detection

1 July 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
Prostate cancer (PCa) is the second most common cancer in men with an estimated prevalence of 1.1 million worldwide in 2012. This heterogeneous disease resulted in approximately 307,000 deaths, making it the fifth leading cause of cancer-related death in men...